
If approved, how will MDMA-assisted therapy impact clinical psychiatry? The CEO of Lykos Therapeutics shares her thoughts.
Ms Emerson is the CEO Of Lykos Therapeutics.
If approved, how will MDMA-assisted therapy impact clinical psychiatry? The CEO of Lykos Therapeutics shares her thoughts.
Published: June 3rd 2024 | Updated: